goflikicept
Phase 3- Indications
- Idiopathic Recurrent Pericarditis, COVID-19, Inflammation
Company intelligence / Profile preview
TRPharm
Istanbul, Istanbul, Turkeytrpharm.com ↗
- Ownership
- Private
- Employees
- ~35
- Development stage
- Phase 3
01
Overview
TRPharm, now known as Inpharmus since early/mid–2025, specializes in bringing innovative pharmaceutical products to emerging markets with a focus on rare diseases, oncology, inflammatory conditions, virology, and CNS. The company’s lead biologic candidate RPH104 has completed Phase I trials for inflammatory indications. They have multiple oncology assets in their pipeline at various stages. The firm partners with global pharma/biotech companies for market access and co-development.[2][3][4]
- Therapeutic areas
- OncologyRare DiseasesRheumatology
- Modalities
- Small moleculesBiologics
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Doctor Reddy’s LaboratoriesClinigenLeadiantBialSigma-Tau Rare DiseaseCrystalGenomicsToyama ChemicalForesee Pharmaceuticals Co., Ltd.[6]and more than twenty-five total partnerships.[5]
Beyond the preview
Go deeper on TRPharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on TRPharm.